Orally Bioavailable Lipid-Based Constructs

SDG LLC

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application 11/904,937, filed Sep 28, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

Patent	Title	Holder	Status	Expires	Time remaining	Confidence
US 10,568,835	Orally Bioavailable Lipid-Based Constructs SDG, Inc. In force Ends no later than Sep 28, 2027 · Medium confidence	SDG, Inc.	In force	Ends no later than Sep 28, 2027	Ends no later than Sep 28, 2027	Medium confidence
US 11,517,529	Orally Bioavailable Lipid-Based Constructs SDG, Inc. In force Term ends Sep 16, 2028 · High confidence	SDG, Inc.	In force	Term ends Sep 16, 2028	Term ends Sep 16, 2028	High confidence
US 8,962,015	Orally Bioavailable Lipid-Based Constructs SDG, Inc. In force Term ends Oct 10, 2028 · High confidence	SDG, Inc.	In force	Term ends Oct 10, 2028	Term ends Oct 10, 2028	High confidence
Application 18/357,721	Orally Bioavailable Lipid-Based Constructs SDG, Inc. Abandoned Abandoned Oct 11, 2023	SDG, Inc.	Abandoned	Abandoned Oct 11, 2023	not computed

4 of 4 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.

3 of these are in force and held by SDG LLC.

Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.